Eugenics, Environmental Ruin, and Surveillance: The Story of Silicon Valley
By Edward Ongweso Jr.,
The Nation
| 06. 23. 2023
In the opening pages of his magisterial Bay Area history, Imperial San Francisco, historian Gray Brechin presents his book as an attempt “to answer the question raised by the kind of cities we build today: Are they worth it?” It’s a deceptively simple question, and it reemerges when we discuss San Francisco and its discontents.
From the city’s earliest days, visionaries looked at San Francisco and saw an heir to Rome. Brechin points to Army scout John C. Frémont, who said he named the bay’s mouth “Chrysopylae (Golden gate) on “the same principle that the harbor of Byzantium (Constantinople afterwards) was called Chrysoceras (Golden horn).”
Brechin also discusses Emanuel Leutze, who painted a mural on a wall in the House wing of the Capitol called Westward the Course of Empire Takes Its Way, which depicts settlers seeing California for the first time. “To Leutze’s cultivated sensibility, these were more than settlers entering California,” Brechin writes, “they were both the Israelites entering Canaan and the holy family of the New World.” Brechin describes a party attended by Leutze where the painter...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...